Exchange: OTC·Updated 12:19 PM EDT

IMUC ImmunoCellular Therapeutics, Ltd.

$0.20
$0.068
(51.52%)
Today
Mkt Cap$25.3M
Vol39.00

About IMUC

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded by Eli Goldberger and Shalom Z. Hirschman on March 20, 1987 and is headquartered in Montvale, NJ.
50

Neutral Sentiment

How do you feel about IMUC?

Advertisement|Remove ads.